KT Corporation - 030200.KS

030200.KS Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
030200.KS	2.5	4.9	2.2	7.1	23.9	36.1	44.0	76.1	54.2	59.8
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 030200.KS with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	030200.KS
name	KT Corporation
price	45950
changes percentage	2.4526
change	1100
day low	44650
day high	45950
year high	50000
year low	33000
market cap	11295708835500
price avg 50	44739
price avg 200	39843.75
exchange	KSC
volume	435415
avg volume	820799
open	44650
previous close	44850
eps	0
pe	None
earnings announcement	2025-02-06T10:59:00.000+0000
shares outstanding	245826090
timestamp	2025-01-17 06:30:21

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 63.7%

Overall Quarterly Financial Health: 51.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	26287201000000	25650011000000	2.48
gross profit	8531848000000	15911065000000	-46.38
gross profit ratio	0.32	0.62	-47.68
research and development expenses	63180000000	174936000000	-63.88
operating expenses	508010000000	14193205000000	-96.42
interest income	279607000000	271925000000	2.83
interest expense	356345000000	293854000000	21.27
ebitda	5536267000000	5858410000000	-5.50
ebitdaratio	0.21	0.22	-6.18
operating income	1428449000000	1690088000000	-15.48
operating income ratio	0.05	0.07	-17.53
net income	993325000000	1260470000000	-21.19
net income ratio	0.04	0.05	-23.10
eps	3981.74	5211.87	-23.60

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 26,287,201 million in 2023 from 25,650,011 million in 2022 representing a change of 2.48%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 63,180 million in 2023 from 174,936 million in 2022 representing a change of -63.88%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Net Income: Net income increased to 993,325 million in 2023 from 1,260,470 million in 2022 representing a change of -21.19%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 8,531,848 million in 2023 from 15,911,065 million in 2022 representing a change of -46.38%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 508,010 million in 2023 from 14,193,205 million in 2022 representing a change of -96.42%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 5,536,267 million in 2023 from 5,858,410 million in 2022 representing a change of -5.5%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,428,449 million in 2023 from 1,690,088 million in 2022 representing a change of -15.48%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 3981.74 in 2023 from 3981.74 in 2022 representing a change of -23.6%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	6654615000000	6546399000000	1.65
gross profit	4254174000000	5016299000000	-15.19
gross profit ratio	0.64	0.77	-16.57
research and development expenses	44505000000	43144000000	3.15
operating expenses	3790064000000	3846839000000	-1.48
interest income	74441000000	65110000000	14.33
interest expense	83201000000	91039000000	-8.61
ebitda	1571066000000	1461885000000	7.47
ebitdaratio	0.24	0.22	5.72
operating income	464110000000	493986000000	-6.05
operating income ratio	0.07	0.08	-7.58
net income	357341000000	393025000000	-9.08
net income ratio	0.05	0.06	-10.56
eps	1451.69	1597.6	-9.13

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 6,654,615 million in 2024Q3 from 6,546,399 million in 2024Q2 representing a change of 1.65%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 44,505 million in 2024Q3 from 43,144 million in 2024Q2 representing a change of 3.15%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 3,790,064 million in 2024Q3 from 3,846,839 million in 2024Q2 representing a change of -1.48%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,571,066 million in 2024Q3 from 1,461,885 million in 2024Q2 representing a change of 7.47%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 4,254,174 million in 2024Q3 from 5,016,299 million in 2024Q2 representing a change of -15.19%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Income: Operating income decreased to 464,110 million in 2024Q3 from 493,986 million in 2024Q2 representing a change of -6.05%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 357,341 million in 2024Q3 from 393,025 million in 2024Q2 representing a change of -9.08%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1451.69 in 2024Q3 from 1451.69 in 2024Q2 representing a change of -9.13%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	42791647000000	40980681000000	4.42
total liabilities	24249072000000	22565958000000	7.46
total equity	18542575000000	18414723000000	0.69
cash and cash equivalents	2879554000000	2449062000000	17.58
short term investments	1440200000000	1322452000000	8.90
long term investments	4281650000000	3982206000000	7.52
total current assets	14594246000000	12681532000000	15.08
total non current assets	28197401000000	28299149000000	-0.36
total current liabilities	13247637000000	10699268000000	23.82
total non current liabilities	11001435000000	11866690000000	-7.29
common stock	1564499000000	1564499000000	0.00
retained earnings	14475867000000	14257343000000	1.53
total debt	11398075000000	10006685000000	13.90

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 42,791,647 million in 2023 from 40,980,681 million in 2022 representing a change of 4.42%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 18,542,575 million in 2023 from 18,414,723 million in 2022 representing a change of 0.69%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,879,554 million in 2023 from 2,449,062 million in 2022 representing a change of 17.58%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 1,440,200 million in 2023 from 1,322,452 million in 2022 representing a change of 8.9%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 14,594,246 million in 2023 from 12,681,532 million in 2022 representing a change of 15.08%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 14,475,867 million in 2023 from 14,257,343 million in 2022 representing a change of 1.53%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 24,249,072 million in 2023 from 22,565,958 million in 2022 representing a change of 7.46%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 13,247,637 million in 2023 from 10,699,268 million in 2022 representing a change of 23.82%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 11,398,075 million in 2023 from 10,006,685 million in 2022 representing a change of 13.9%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	42750388000000	43144379000000	-0.91
total liabilities	23563985000000	24162478000000	-2.48
total equity	19186403000000	18981901000000	1.08
cash and cash equivalents	3953893000000	3786724000000	4.41
short term investments	1077715000000	1219796000000	-11.65
long term investments	4449791000000	8293028000000	-46.34
total current assets	15196969000000	15175181000000	0.14
total non current assets	27553419000000	27969198000000	-1.49
total current liabilities	14644486000000	14095215000000	3.90
total non current liabilities	8919499000000	10067263000000	-11.40
common stock	1564499000000	1564499000000	0.00
retained earnings	14675161000000	14452660000000	1.54
total debt	9768624000000	11289010000000	-13.47

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 42,750,388 million in 2024Q3 from 43,144,379 million in 2024Q2 representing a change of -0.91%. Suggesting a decrease in asset holdings.

  Short Term Investments: Short Term Investments decreased to 1,077,715 million in 2024Q3 from 1,219,796 million in 2024Q2 representing a change of -11.65%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 14,644,486 million in 2024Q3 from 14,095,215 million in 2024Q2 representing a change of 3.9%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 23,563,985 million in 2024Q3 from 24,162,478 million in 2024Q2 representing a change of -2.48%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 19,186,403 million in 2024Q3 from 18,981,901 million in 2024Q2 representing a change of 1.08%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 3,953,893 million in 2024Q3 from 3,786,724 million in 2024Q2 representing a change of 4.41%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 15,196,969 million in 2024Q3 from 15,175,181 million in 2024Q2 representing a change of 0.14%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 14,675,161 million in 2024Q3 from 14,452,660 million in 2024Q2 representing a change of 1.54%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 9,768,624 million in 2024Q3 from 11,289,010 million in 2024Q2 representing a change of -13.47%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	430492000000	-570530000000	175.45
operating cash flow	5503289000000	3597065000000	52.99
free cash flow	1330567000000	-390072000000	441.11
capital expenditure	-4172722000000	-3987137000000	-4.65
depreciation and amortization	3810131000000	3710666000000	2.68
deferred income tax	335367000000	506404000000	-33.77
stock based compensation	0	0	NaN
accounts payables	121515000000	-368355000000	132.99
inventory	-249923000000	-170773000000	-46.35
acquisitions net	-51561000000	-280494000000	81.62
investments in property plant and equipment	-4172722000000	-3987137000000	-4.65
net cash used for investing activites	-4620508000000	-4838643000000	4.51
debt repayment	-300933000000	1012637000000	-129.72
common stock issued	0	0	NaN
common stock repurchased	-300086000000	0	NaN
dividends paid	-526826000000	-450393000000	-16.97
net cash used provided by financing activities	-452792000000	669331000000	-167.65
cash at end of period	2879554000000	2449062000000	17.58
accounts receivables	-1209550000000	-43787000000	-2662.35
cash at beginning of period	2449062000000	3019592000000	-18.89

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 430,492 million in 2023 from -570,530 million in 2022 representing a change of 175.45%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 5,503,289 million in 2023 from 3,597,065 million in 2022 representing a change of 52.99%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,330,567 million in 2023 from -390,072 million in 2022 representing a change of 441.11%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -4,172,722 million in 2023 from -3,987,137 million in 2022 representing a change of -4.65%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 121,515 million in 2023 from 368,355 million in 2022 representing a change of 132.99%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -1,209,550 million in 2023 from -43,787 million in 2022 representing a change of -2662.35%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Dividends Paid: Dividends Paid decreased to -526,826 million in 2023 from -450,393 million in 2022 representing a change of -16.97%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	1163728000000	2122059000000	-45.16
free cash flow	287984000000	1478355000000	-80.52
capital expenditure	-875744000000	-643704000000	-36.05
depreciation and amortization	978798000000	979113000000	-0.03
deferred income tax	125896000000	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-170595000000	237984000000	-171.68
accounts payables	-193921000000	157002000000	-223.51
inventory	57673000000	-72514000000	179.53
acquisitions net	-484000000	0	NaN
investments in property plant and equipment	-827744000000	-643704000000	-28.59
net cash used for investing activites	-570095000000	-522133000000	-9.19
debt repayment	-298734000000	-189977000000	-57.25
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-122955000000	-626414000000	80.37
net cash used provided by financing activities	-423142000000	-844815000000	49.91
net change in cash	167169000000	786037000000	-78.73
cash at end of period	3953893000000	3786724000000	4.41
cash at beginning of period	3786724000000	3000687000000	26.20

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 167,169 million in 2024Q3 from 786,037 million in 2024Q2 representing a change of -78.73%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 1,163,728 million in 2024Q3 from 2,122,059 million in 2024Q2 representing a change of -45.16%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 287,984 million in 2024Q3 from 1,478,355 million in 2024Q2 representing a change of -80.52%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 125,896 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 193,921 million in 2024Q3 from 157,002 million in 2024Q2 representing a change of -223.51%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -875,744 million in 2024Q3 from -643,704 million in 2024Q2 representing a change of -36.05%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -170,595 million in 2024Q3 from 237,984 million in 2024Q2 representing a change of -171.68%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -122,955 million in 2024Q3 from -626,414 million in 2024Q2 representing a change of 80.37%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q3 2022 Earnings call transcript
Q2 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	105372.16	105888.81	-0.49
net income per share	3981.74	5203.49	-23.48
operating cash flow per share	22059.92	14849.46	48.56
free cash flow per share	5333.57	-1610.3	431.22
cash per share	17315.72	15569.63	11.21
book value per share	74327.85	76019.97	-2.23
tangible book value per share	64170.88	63099.34	1.70
shareholders equity per share	67064.61	68578.65	-2.21
interest debt per share	47117.56	42522.86	10.81
market cap	8519402958800	7872648290000	8.22
enterprise value	17037923958800	15430271290000	10.42
pe ratio	8.58	6.25	37.32
price to sales ratio	0.32	0.31	5.59
pocfratio	1.55	2.19	-29.27
pfcf ratio	6.4	-20.18	131.72
pb ratio	0.51	0.47	7.45
ptb ratio	0.51	0.47	7.45
ev to sales	0.65	0.6	7.74
enterprise value over ebitda	3.08	2.63	16.84
ev to operating cash flow	3.1	4.29	-27.83
ev to free cash flow	12.81	-39.56	132.37
earnings yield	0.12	0.16	-27.18
free cash flow yield	0.16	-0.05	415.21
debt to equity	0.68	0.6	13.10
debt to assets	0.27	0.24	9.08
net debt to ebitda	1.54	1.29	19.27
current ratio	1.1	1.19	-7.06
interest coverage	4.01	5.75	-30.30
income quality	5.66	2.59	118.38
dividend yield	0.06	0.06	8.09
payout ratio	0.53	0.36	48.43
sales general and administrative to revenue	0.18	0.18	-1.06
research and ddevelopement to revenue	0.0	0.01	-64.76
intangibles to total assets	0.06	0.08	-22.47
capex to operating cash flow	0.76	1.11	-31.60
capex to revenue	0.16	0.16	2.12
capex to depreciation	1.1	1.07	1.92
stock based compensation to revenue	0	0	NaN
graham number	77512.98	89605.2	-13.50
roic	0.03	0.04	-16.00
return on tangible assets	0.02	0.03	-25.91
graham net net	-56339.23	-57238.29	1.57
working capital	1346609000000	1982264000000	-32.07
tangible asset value	16008714000000	15284890000000	4.74
net current asset value	-9654826000000	-9884426000000	2.32
invested capital	20057512000000	21164610000000	-5.23
average receivables	6636601500000	5596529500000	18.58
average payables	1224133500000	1343831500000	-8.91
average inventory	848771000000	611668000000	38.76
days sales outstanding	99.61	86.8	14.76
days payables outstanding	26.68	43.12	-38.13
days of inventory on hand	20.32	26.58	-23.56
receivables turnover	3.66	4.21	-12.86
payables turnover	13.68	8.46	61.63
inventory turnover	17.96	13.73	30.82
roe	0.06	0.08	-21.75
capex per share	16726.34	16459.77	1.62

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 8.58 on 2023-12-31 from 6.25 on 2022-12-31, representing a change of 37.32%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.10 on 2023-12-31 from 1.19 on 2022-12-31, representing a change of -7.06%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.68 on 2023-12-31 from 0.60 on 2022-12-31, representing a change of 13.10%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
030200.KS
calendar year	2024	2024	NaN
revenue per share	27070.45	26637.71	1.62
net income per share	1453.64	1599.24	-9.10
operating cash flow per share	4733.95	8634.79	-45.18
free cash flow per share	1171.5	6015.52	-80.53
cash per share	20468.19	20371.84	0.47
book value per share	78048.78	77238.54	1.05
tangible book value per share	69160.64	68016.76	1.68
shareholders equity per share	70392.38	69639.75	1.08
interest debt per share	40076.45	46306.13	-13.45
market cap	9882196155000	9068428060200	8.97
enterprise value	15696927155000	16570714060200	-5.27
pe ratio	6.91	5.77	19.86
price to sales ratio	1.49	1.39	7.20
pocfratio	8.49	4.27	98.71
pfcf ratio	34.32	6.13	459.41
pb ratio	0.57	0.53	7.78
ptb ratio	0.57	0.53	7.78
ev to sales	2.36	2.53	-6.81
enterprise value over ebitda	9.99	11.34	-11.86
ev to operating cash flow	13.49	7.81	72.73
ev to free cash flow	54.51	11.21	386.28
earnings yield	0.04	0.04	-16.57
free cash flow yield	0.03	0.16	-82.12
debt to equity	0.56	0.66	-14.42
debt to assets	0.23	0.26	-12.67
net debt to ebitda	3.7	5.13	-27.88
current ratio	1.04	1.08	-3.61
interest coverage	5.58	5.43	2.80
income quality	3.04	5.4	-43.79
dividend yield	0.01	0.07	-81.99
payout ratio	0.34	1.59	-78.41
sales general and administrative to revenue	0.18	0.45	-60.96
research and ddevelopement to revenue	0.01	0.01	1.48
intangibles to total assets	0.05	0.05	-2.70
capex to operating cash flow	0.75	0.3	148.08
capex to revenue	0.13	0.1	33.84
capex to depreciation	0.89	0.66	36.09
stock based compensation to revenue	0	0	NaN
graham number	47982.38	50058.42	-4.15
roic	0.01	0.01	-3.57
return on tangible assets	0.01	0.01	-8.38
graham net net	-52335.77	-54976.23	4.80
working capital	552483000000	1079966000000	-48.84
tangible asset value	17001468000000	16715585000000	1.71
net current asset value	-8367016000000	-8987297000000	6.90
invested capital	18513784000000	19224676000000	-3.70
average receivables	6918972000000	7125457500000	-2.90
average payables	1319278500000	1344739500000	-1.89
average inventory	933610000000	931572000000	0.22
days sales outstanding	94.05	94.64	-0.63
days payables outstanding	45.39	83.99	-45.96
days of inventory on hand	33.86	56.7	-40.28
receivables turnover	0.96	0.95	0.64
payables turnover	1.98	1.07	85.04
inventory turnover	2.66	1.59	67.45
roe	0.02	0.02	-10.08
capex per share	3562.46	2619.27	36.01

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -10.08%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 6.91 on 2024-09-30 Q3 from 5.77 on 2024-06-30 Q2, representing a change of 19.86%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.56 on 2024-09-30 Q3 from 0.66 on 2024-06-30 Q2, representing a change of -14.42%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.04 on 2024-09-30 Q3 from 1.08 on 2024-06-30 Q2, representing a change of -3.61%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 35966.04 which is lower than current price 45950, indicates the company may be overvalued.